Cite
Paraneoplastic tubulointerstitial nephritis exacerbated by immune checkpoint inhibitor
MLA
Thomas Paul Scherer, et al. Paraneoplastic Tubulointerstitial Nephritis Exacerbated by Immune Checkpoint Inhibitor. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....12700bc0e3eb517a1bf974c5c235e65e&authtype=sso&custid=ns315887.
APA
Thomas Paul Scherer, Richard Cathomas, Thomas Fehr, Ariana Gaspert, Raeto Strebel, & Karim Alexander Saba. (2021). Paraneoplastic tubulointerstitial nephritis exacerbated by immune checkpoint inhibitor.
Chicago
Thomas Paul Scherer, Richard Cathomas, Thomas Fehr, Ariana Gaspert, Raeto Strebel, and Karim Alexander Saba. 2021. “Paraneoplastic Tubulointerstitial Nephritis Exacerbated by Immune Checkpoint Inhibitor,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....12700bc0e3eb517a1bf974c5c235e65e&authtype=sso&custid=ns315887.